Trial
NCT04802057
Safety and Tolerability Study in Adults With Cold Agglutinin Disease Previously Treated With SAR445088 or Never Treated With SAR445088
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Bioverativ, a Sanofi company
Collaborators
—
Condition
Autoimmune Haemolytic Anaemia
Intervention
SAR445088
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-09-11